Description
4-1BBL Antibodyis available at Gentaur for Next week Delivery.
Description: Human 4-1BB Ligand (4-1BBL) is a member of the emerging family of Ligands with structural homology to tumor necrosis factor. Human 4-1BBL is a 19.5 kDa protein containing 185 amino acid residues, comprising the TNF-like extra-cellular domain of 4-1BBL.
Immunogen Sequence:Recombinant human 4-1BBL (Cat.# 4369-20)
Target Alternative Name:TNFSF9, CD137L, 41BBL, 4 1BBL
Species Reactivities:Human
Tag Line:/
Formulation:30 µg (0.5 mg/ml) affinity purified rabbit anti-human 4-1BBL polyclonal antibody in PBS (pH 7.2) containing 30% glycerol, 0.5% BSA, 0.01% thimerosal.
Purification: Affinity purified
Application:Western blot, and Immunohistochemistry
Positive Control:Recombinant human 4-1BBL (Cat.# 4369-20)
Application And Usages:Western Blot analysis (0.5-4.0 µg/ml) and Immunohistochemistry (5 µg/ml). However, the optimal conditions should be determined individually.
Handling:The antibody solution should be gently mixed before use.
Additional Information
| Size: | 30 µg | 
| Antibody Target: | 4-1BBL | 
| Category: | 4-1BBL | 
| Lot Number: | 51269 | 
| Host: | Rabbit | 
| Antibody Type: | Polyclonal | 
| Isotype: | Rabbit IgG | 
| Accession Number: | P41273 | 
| Gene Id: | 8744 | 
| Concentration: | 0.5 mg/ml | 
| Appearance: | Colorless liquid | 
| Form: | Liquid | 
| Storage Condition: | -20 °C | 
| Shipping Condition: | gel pack | 
| Shelf Life: | 12 months | 
| Country of Animal Origin: | USA | 
| Country of Manufacture: | USA | 
| Usage: | For Research Use Only! Not to be used in humans. | 
| Western Blot Verified: | Verified | 
| Immunocytochemistry Verified: | Verified | 
| Immunofluorescence Verified: | Not Verified | 
| Immunoprecipitation Verified: | Not Verified | 
| FACS Verified: | Not Verified | 
| ELISA Verified: | Not Verified | 
| ChIP Verified: | Not Verified | 
| Flow Cytometry Verified: | Not Verified | 
 
             
             
                                 
                         
                         
             
                                 
                                 
                                